DMAQ vs. ATAK, QFTA, EFHT, SELX, HAIA, JMAC, MCAE, EGOX, OLIT, and WWAC
Should you be buying Deep Medicine Acquisition stock or one of its competitors? The main competitors of Deep Medicine Acquisition include Aurora Technology Acquisition (ATAK), Quantum FinTech Acquisition (QFTA), EF Hutton Acquisition Co. I (EFHT), Semilux International (SELX), Healthcare AI Acquisition (HAIA), Maxpro Capital Acquisition (JMAC), Mountain Crest Acquisition Corp. III (MCAE), Next.e.GO (EGOX), OmniLit Acquisition (OLIT), and Worldwide Webb Acquisition (WWAC). These companies are all part of the "holding & other investment offices" industry.
Aurora Technology Acquisition (NASDAQ:ATAK) and Deep Medicine Acquisition (NASDAQ:DMAQ) are both small-cap unclassified companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, community ranking, institutional ownership, risk and dividends.
Aurora Technology Acquisition and Deep Medicine Acquisition both received 0 outperform votes by MarketBeat users.
54.1% of Aurora Technology Acquisition shares are held by institutional investors. Comparatively, 18.4% of Deep Medicine Acquisition shares are held by institutional investors. 45.8% of Aurora Technology Acquisition shares are held by insiders. Comparatively, 1.7% of Deep Medicine Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Aurora Technology Acquisition has a beta of -0.35, suggesting that its share price is 135% less volatile than the S&P 500. Comparatively, Deep Medicine Acquisition has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500.
In the previous week, Deep Medicine Acquisition's average media sentiment score of 0.67 beat Aurora Technology Acquisition's score of 0.00 indicating that Aurora Technology Acquisition is being referred to more favorably in the media.
Summary
Aurora Technology Acquisition beats Deep Medicine Acquisition on 3 of the 4 factors compared between the two stocks.
Get Deep Medicine Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for DMAQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DMAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Deep Medicine Acquisition Competitors List
Related Companies and Tools
